The absence of formal data does not mean absence of risk
Many patients taking GLP-1 agonists have experienced persistent vomiting, intestinal blockages, and other digestive complications that have severely impacted their quality of life and required urgent medical attention and/or repeat hospital visits
Abstract Purpose of Review Obesity pharmacotherapy has become increasingly relevant in older adults due to challenges in lifestyle modification and the burden of non-communicable diseases
The rise of dual GLP-1/GIP agonists like tirzepatide signals a pivotal shift in how we approach both diabetes and obesity
Quick Summary: A weight-loss clinic near Harrisburg, PA offers personalized programs incorporating medical evaluation, dietary planning, metabolic support, behavioral counseling, and potentially medication assistance to support sustainable weight loss and improve metabolic health outcomes
Notably, ICER does not negotiate prices